Semaglutide mimics the action of the GLP-1 hormone, stimulating insulin release and reducing glucagon secretion. This improves glycaemic control, reduces appetite and promotes weight loss.
Recommended for:
- patients with type 2 diabetes
- overweight and obese patients
- individuals with metabolic syndrome
- patients with insufficient glucose control on standard therapy
Studies:
Clinical trials (SUSTAIN, STEP) demonstrated Semaglutide’s ability to reduce HbA1c, lower body weight and improve cardiovascular outcomes.
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)